Functional Capacity Impairment in Long COVID After 17 Months of Severe Acute Disease

Fernanda Facioli dos Reis Borges, Andrezza Cristina Barbosa Braga, Bernardo Silva Viana, Jefferson Valente, João Marcos Bemfica, Thaís Sant’Anna, Cássia da Luz Goulart, Fernando Almeida-Val and Guilherme Peixoto Tinoco Arêas ()
Additional contact information
Fernanda Facioli dos Reis Borges: Human Movement Science Graduation Program, Universidade Federal do Amazonas, Manaus 6200, Brazil
Andrezza Cristina Barbosa Braga: Physical Therapy Department, Universidade Federal do Amazonas, Manaus 6200, Brazil
Bernardo Silva Viana: Medicine Department, Universidade Federal do Amazonas, Manaus 6200, Brazil
Jefferson Valente: Tropical Medicine Graduation Program, Universidade Estadual do Amazonas, Manaus 3578, Brazil
João Marcos Bemfica: Tropical Medicine Graduation Program, Universidade Estadual do Amazonas, Manaus 3578, Brazil
Thaís Sant’Anna: Physical Therapy Department, Universidade Federal do Amazonas, Manaus 6200, Brazil
Cássia da Luz Goulart: Physical Therapy Department, Universidade de Brasília, Campus Ceilandia, Brasília 72220-275, Brazil
Fernando Almeida-Val: Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus 69040-000, Brazil
Guilherme Peixoto Tinoco Arêas: Physiological Science Department, Universidade Federal do Amazonas, Manaus 6200, Brazil

IJERPH, 2025, vol. 22, issue 2, 1-14

Abstract: Long COVID represents a significant challenge in understanding the prolonged impact of the disease. Despite its increasing recognition, detailed insights into the long-term cardiopulmonary consequences remain sparse. This study aimed to evaluate the functional capacity of individuals with persistent symptoms after severe COVID-19 infection compared to control individuals without symptomatic COVID or mild COVID after 17 months. This is a case-control study assessing 34 individuals divided into two groups regarding functional capacity by distance in a 6-min walk test (D6MWT) associated with gas analysis, spirometry, respiratory muscle strength, and quality of life. During the 6 MWT, an important lower heart rate (HR) was observed for the COVID group (106 ± 10 bpm, difference mean: 21.3; p < 0.001), with greater exertional perception (Borg dyspnea: 4.5 [2.0–9.0], p < 0.001 and Borg fatigue: 4.0 [2.0–7.0], p = 0.01), a significant decrease in the distance covered (416 ± 94 m, difference mean: 107; p = 0.002), and a low value of O 2 uptake ( V ˙ O2 ) (11 ± 5.0 mL/(kg min), difference mean: 8.3; p = 0.005) and minute ventilation (22 ± 8 L/min, difference mean: 18.6; p = 0.002), in addition to very low quality of life scores. Regression analysis showed a significant association between D6MWT and Borg fatigue and Borg dyspnea at rest ( p = 0.003; p = 0.009). V ˙ O2 and HR were also significantly associated with the outcomes of the D6MWT ( p = 0.04 and p = 0.004, respectively). In conclusion, individuals who have severe COVID-19 and persist with symptoms have low functional capacity, low V ˙ O2 , low HR behavior, and low quality of life.

Keywords: post-acute COVID-19 syndrome; walk test; functional capacity; oxygen consumption; quality of life (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2025
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/22/2/276/pdf (application/pdf)
https://www.mdpi.com/1660-4601/22/2/276/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:22:y:2025:i:2:p:276-:d:1590532

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().